Keywords
Last Name
Institution

Thomas Leist

TitleProfessor
InstitutionThomas Jefferson University
DepartmentNeurology
Address900 Walnut Street
Philadelphia PA 19107
Phone215-955-1234

 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Comi G, Freedman MS, Kappos L, Olsson TP, Miller AE, Wolinsky JS, O'Connor PW, Benamor M, Dukovic D, Truffinet P, Leist TP. Pooled safety and tolerability data from four placebo-controlled teriflunomide studies and extensions. Mult Scler Relat Disord. 2016 Jan; 5:97-104.
    View in: PubMed
  2. Rasouli J, Ciric B, Imitola J, Gonnella P, Hwang D, Mahajan K, Mari ER, Safavi F, Leist TP, Zhang GX, Rostami A. Expression of GM-CSF in T Cells Is Increased in Multiple Sclerosis and Suppressed by IFN-ß Therapy. J Immunol. 2015 Jun 1; 194(11):5085-93.
    View in: PubMed
  3. Coyle PK, Cohen BA, Leist T, Markowitz C, Oleen-Burkey M, Schwartz M, Tullman MJ, Zwibel H. Therapy optimization in multiple sclerosis: a prospective observational study of therapy compliance and outcomes. BMC Neurol. 2014; 14(1):49.
    View in: PubMed
  4. Leist T. Thomas Leist. Lancet Neurol. 2014 Mar; 13(3):244.
    View in: PubMed
  5. Leist TP, Comi G, Cree BA, Coyle PK, Freedman MS, Hartung HP, Vermersch P, Casset-Semanaz F, Scaramozza M. Effect of oral cladribine on time to conversion to clinically definite multiple sclerosis in patients with a first demyelinating event (ORACLE MS): a phase 3 randomised trial. Lancet Neurol. 2014 Mar; 13(3):257-67.
    View in: PubMed
  6. Leist T, Hunter SF, Kantor D, Markowitz C. Novel therapeutics in multiple sclerosis management: clinical applications. Am J Med. 2014 Jan; 127(1):S2.
    View in: PubMed
  7. Morse CL, Schultheis MT, McKeever JD, Leist T. Multitasking in multiple sclerosis: can it inform vocational functioning? Arch Phys Med Rehabil. 2013 Dec; 94(12):2509-14.
    View in: PubMed
  8. Leist TP, Weissert R. Cladribine: mode of action and implications for treatment of multiple sclerosis. Clin Neuropharmacol. 2011 Jan-Feb; 34(1):28-35.
    View in: PubMed
  9. Leist TP, Marks S. Magnetic resonance imaging and treatment effects of multiple sclerosis therapeutics. Neurology. 2010 Jan 5; 74 Suppl 1:S54-61.
    View in: PubMed
  10. Techavipoo U, Okai AF, Lackey J, Shi J, Dresner MA, Leist TP, Lai S. Toward a practical protocol for human optic nerve DTI with EPI geometric distortion correction. J Magn Reson Imaging. 2009 Oct; 30(4):699-707.
    View in: PubMed
  11. Techavipoo U, Lackey J, Shi J, Leist T, Lai S. Phase labeling using sensitivity encoding (PLUS): data acquisition and image reconstruction for geometric distortion correction in EPI. Magn Reson Med. 2009 Mar; 61(3):650-8.
    View in: PubMed
  12. Spain RI, Leist TP, De Sousa EA. When metals compete: a case of copper-deficiency myeloneuropathy and anemia. Nat Clin Pract Neurol. 2009 Feb; 5(2):106-11.
    View in: PubMed
  13. Spain RI, Maltenfort M, Sergott RC, Leist TP. Thickness of retinal nerve fiber layer correlates with disease duration in parallel with corticospinal tract dysfunction in untreated multiple sclerosis. J Rehabil Res Dev. 2009; 46(5):633-42.
    View in: PubMed
  14. Leist TP, Vermersch P. The potential role for cladribine in the treatment of multiple sclerosis: clinical experience and development of an oral tablet formulation. Curr Med Res Opin. 2007 Nov; 23(11):2667-76.
    View in: PubMed
  15. Kasper LH, Everitt D, Leist TP, Ryan KA, Mascelli MA, Johnson K, Raychaudhuri A, Vollmer T. A phase I trial of an interleukin-12/23 monoclonal antibody in relapsing multiple sclerosis. Curr Med Res Opin. 2006 Sep; 22(9):1671-8.
    View in: PubMed
  16. Okai AF, Muppidi S, Bagla R, Leist TP. Progressive necrotizing myelopathy: part of the spectrum of neuromyelitis optica? Neurol Res. 2006 Apr; 28(3):354-9.
    View in: PubMed
  17. Oh U, Yamano Y, Mora CA, Ohayon J, Bagnato F, Butman JA, Dambrosia J, Leist TP, McFarland H, Jacobson S. Interferon-beta1a therapy in human T-lymphotropic virus type I-associated neurologic disease. Ann Neurol. 2005 Apr; 57(4):526-34.
    View in: PubMed
  18. Vyshkina T, Shugart YY, Birnbaum G, Leist TP, Kalman B. Association of haplotypes in the beta-chemokine locus with multiple sclerosis. Eur J Hum Genet. 2005 Feb; 13(2):240-7.
    View in: PubMed
  19. Vyshkina T, Banisor I, Shugart YY, Leist TP, Kalman B. Genetic variants of Complex I in multiple sclerosis. J Neurol Sci. 2005 Jan 15; 228(1):55-64.
    View in: PubMed
  20. Zivadinov R, Leist TP. Clinical-magnetic resonance imaging correlations in multiple sclerosis. J Neuroimaging. 2005; 15(4 Suppl):10S-21S.
    View in: PubMed
  21. Vyshkina T, Leist TP, Shugart YY, Kalman B. CD45 (PTPRC) as a candidate gene in multiple sclerosis. Mult Scler. 2004 Dec; 10(6):614-7.
    View in: PubMed
  22. Kalman B, Leist TP. Familial multiple sclerosis and other inherited disorders of the white matter. Neurologist. 2004 Jul; 10(4):201-15.
    View in: PubMed
  23. Kalman B, Leist TP. A mitochondrial component of neurodegeneration in multiple sclerosis. Neuromolecular Med. 2003; 3(3):147-58.
    View in: PubMed
  24. Kalman B, Albert RH, Leist TP. Genetics of multiple sclerosis: determinants of autoimmunity and neurodegeneration. Autoimmunity. 2002 Jul; 35(4):225-34.
    View in: PubMed
Leist's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
Co-Authors
_
Similar People
_
Same Department
Physical Neighbors
_